Gene · 10892
Papers2,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fungal Colonization and Infections-Interactions with Other Human Diseases. | Pathogens | 2022 | 35215155 | PubTator, text mining | PubMed |
| Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma. | Mol Ther Nucleic Acids | 2022 | 35211354 | PubTator, text mining | PubMed |
| The Pseudokinase TRIB1 in Immune Cells and Associated Disorders. | Cancers (Basel) | 2022 | 35205759 | PubTator, text mining | PubMed |
| Low Mutational Burden of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue in Patients with Primary Sjogren's Syndrome. | Cancers (Basel) | 2022 | 35205758 | PubTator, text mining | PubMed |
| Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma. | Cancers (Basel) | 2022 | 35205754 | PubTator, text mining | PubMed |
| Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum. | Biology (Basel) | 2022 | 35205133 | PubTator, text mining | PubMed |
| The Paracaspase MALT1 in Cancer. | Biomedicines | 2022 | 35203553 | PubTator, text mining | PubMed |
| Mechanistic impact of oligomer poisoning by dominant-negative CARD11 variants. | iScience | 2022 | 35198875 | PubTator, text mining | PubMed |
| The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies. | Mol Ther | 2022 | 35176485 | PubTator, text mining | PubMed |
| KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders. | Cancers (Basel) | 2022 | 35158933 | PubTator, text mining | PubMed |
| CARD9 Forms an Alternative CBM Complex in Richter Syndrome. | Cancers (Basel) | 2022 | 35158799 | PubTator, text mining | PubMed |
| B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages. | J Transl Med | 2022 | 35144648 | PubTator, text mining | PubMed |
| CCR6 activation links innate immune responses to mucosa-associated lymphoid tissue lymphoma development. | Haematologica | 2022 | 35142152 | PubTator, text mining | PubMed |
| What Prognostic Markers Should Be Evaluated in Marginal Zone Lymphoma? A Survey Among Leading International Experts. | Hemasphere | 2022 | 35141471 | PubTator, text mining | PubMed |
| CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy. | NPJ Syst Biol Appl | 2022 | 35132075 | PubTator, text mining | PubMed |
| Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas. | World J Gastrointest Oncol | 2022 | 35116108 | PubTator, text mining | PubMed |
| Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum. | World J Gastrointest Oncol | 2022 | 35116103 | PubTator, text mining | PubMed |
| Identification of multiple sclerosis-related genes regulated by EBV-encoded microRNAs in B cells. | Mult Scler Relat Disord | 2022 | 35114606 | PubTator, text mining | PubMed |
| CRISPR activation and interference screens decode stimulation responses in primary human T cells. | Science | 2022 | 35113687 | PubTator, text mining | PubMed |
| Helicobacter pylori-negative extra-nodal marginal zone B-cell lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) type following Roux-en-Y Gastric Bypass (RYGB). | Clin Case Rep | 2022 | 35106160 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10892/papers?page=32